Laying the foundations for innovative treatments

On new paths to the goal

Cancer medicine is undergoing a global transformation. This is due to novel technological breakthroughs and numerous discoveries in biomedical research, such as the CRISPR-Cas gene scissors and new insights into the role of the immune system in cancer.

In three research groups, our staff conducts research on central topics in pediatric oncology: leukemias, brain tumors, and stem cell transplantation and immunotherapies Promising findings from the laboratory are quickly transferred to clinical research and the treatment of patients at the University Medical Center Hamburg-Eppendorf. Conversely, the close interaction between patient care and science means that problems from everyday clinical practice are quickly translated into new research questions.

Our researchers investigate the molecular and cellular basis of tumor diseases to decipher pivotal angles for therapeutic intervention. They also develop new technologies for the diagnosis, stratification and treatment of cancer and explore innovative immunotherapies.

"At the Research Institute, cancers are characterized in more detail, and these molecular and immunological findings are fundamental to developing new strategies, exploring them in trials and ultimately improving treatment."
Prof. Dr. Stefan Rutkowski, Direktor der Klinik für Pädiatrische Hämatologie und Onkologie am Universitätsklinikum Hamburg-Eppendorf

Research Report 2021

People, findings and developments from the work of the research institute – reviews and outlooks.
Download PDF (in German)

Light in the dark - modern tumor diagnostics from the research group of Professor Dr. Ulrich Schüller gains acceptance in adult medicine.

The Research Institute for Childhood Cancer Center Hamburg successfully continues exploring the further development of diagnostic procedures.